Alexander Bukreyev | Virology | Excellence in Research

Prof. Dr. Alexander Bukreyev | Virology | Excellence in Research

Prof. Dr. Alexander Bukreyev, University of Texas Medical Branch at Galveston, Excellence in Research

Prof. Dr. Alexander Bukreyev is a Distinguished Professor of Virology and Vaccinology at the University of Texas Medical Branch (UTMB). He serves in the Departments of Pathology and Microbiology & Immunology and holds senior roles in multiple UTMB research centers, including the Sealy Institute for Vaccine Sciences and the Center for Biodefense. An expert in emerging infectious diseases, he is a Fellow of the American Academy of Microbiology. With decades of experience in RNA virus research and BSL-4 pathogen handling, he contributes globally through advisory roles, WHO collaborations, and international vaccine initiatives. πŸ‡ΊπŸ‡Έ

Publication Profile

Google Scholar

πŸŽ“ Education

Prof. Bukreyev earned his Ph.D. in Molecular Biology in 1993 from the State Research Center of Virology and Biotechnology “Vector” in Russia, where he completed the full nucleotide sequencing of the Marburg virus genome. He obtained his M.S. in Pharmacy from Pyatigorsk Pharmaceutical Institute in 1984. His postgraduate education includes extensive biosafety, immunology, and virology training at institutions such as NIH and UTMB. His education reflects a lifelong commitment to combating viral diseases and advancing vaccine science through foundational knowledge and specialized high-containment lab training. πŸ§¬πŸ“˜

πŸ’Ό Experience

Prof. Bukreyev currently serves as a professor at UTMB and has been affiliated with the university since 2010. Prior to this, he was a Staff Scientist and Research Fellow at the NIH’s National Institute of Allergy and Infectious Diseases from 1995 to 2010, working under Dr. Robert Chanock and Dr. Peter Collins. His early career in Russia included senior research roles at the Vector Institute, where he specialized in RNA viruses and high-level biosafety. Across his career, he has led multiple research teams, mentored fellows, and managed work in BSL-3 and BSL-4 labs. πŸ§ͺπŸ”¬

πŸ† Awards and Honors

Prof. Bukreyev was elected Fellow of the American Academy of Microbiology in 2025 and received the UT System STAR Award in 2024. He has convened and co-chaired major international workshops on RNA vaccines and host defense, including for the International Society for Vaccines and the American Society for Virology. He has served on the WHO COVID-19 Animal Model Expert Group and numerous scientific planning committees. His honors reflect global recognition of his leadership in vaccine development, viral immunology, and infectious disease research. 🌍πŸ₯‡

πŸ”¬ Research Focus

Prof. Bukreyev’s research centers on the molecular biology, immunopathology, and vaccinology of emerging RNA viruses, including filoviruses (e.g., Ebola and Marburg), respiratory syncytial virus, and SARS-CoV-2. He develops and evaluates novel vaccine candidates, focusing on live-attenuated and vector-based platforms, and studies viral mechanisms that interfere with host immunity. His lab also explores immune correlates of protection and animal model development. With extensive expertise in BSL-4 pathogens, his work supports global biodefense and pandemic preparedness. πŸ¦ πŸ’‰

Publication Top Notes

  • πŸ“š Taxonomy of the order Mononegavirales: update 2016 – 568 citations, 2016

  • 🦠 Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice – 532 citations, 2004

  • 🧬 2020 taxonomic update for phylum Negarnaviricota… – 398 citations, 2020

  • πŸ“– Taxonomy of the order Mononegavirales: update 2019 – 380 citations, 2019

  • 🧫 Infection of ciliated cells by human parainfluenza virus type 3… – 372 citations, 2005

  • πŸ§ͺ Recombinant respiratory syncytial virus with deleted SH gene… – 337 citations, 1997

  • πŸ§β€πŸ¦ Recombinant RSV with deletion of NS2 or SH gene attenuated in chimpanzees – 333 citations, 1999

  • πŸ’‰ Mucosal immunisation in African green monkeys using attenuated parainfluenza virus… – 332 citations, 2004

  • πŸ›‘ Structural proteins of SARS-CoV contribute to protective immunity – 314 citations, 2004

  • πŸ”¬ Taxonomy of the order Mononegavirales: update 2017 – 275 citations, 2017

Xue-jie Yu | Virology Award | Best Researcher Award

Prof Dr. Xue-jie Yu | Virology Award | Best Researcher Award

Prof Dr. Xue-jie Yu, Wuhan University, China

πŸ‘¨β€βš•οΈ Prof. Dr. Xue-jie Yu is a distinguished expert in infectious diseases, currently a professor at Wuhan University School of Public Health. He earned his MD from Shandong University and his Ph.D. in Cellular Biology and Microbiology from Aix-Marseille University, France. Dr. Yu has held significant roles, including Professor and Dean at Wuhan University School of Health Sciences and faculty positions at the University of Texas Medical Branch. His groundbreaking work on the novel bunyavirus (SFTSV) has been pivotal in understanding its epidemiology and transmission. He is a member of multiple prestigious societies, including the American Society for Rickettsiology and the Chinese Society for Microbiology. πŸŒπŸ”¬

Publication Profile

Google Scholar

πŸ‘¨β€βš•οΈ Education

Prof. Dr. Xue-jie Yu received his MD from Shandong University, a Master’s in Preventive Medicine from the Chinese Academy for Preventive Medicine, and a Ph.D. in Cellular Biology and Microbiology from Aix-Marseille University.

πŸŽ“ Work Experience

From 1997 to 2016, he held various academic positions at the University of Texas Medical Branch. He later served as Professor and Dean at Wuhan University School of Health Sciences and is currently a professor at Wuhan University School of Public Health.

 

Research Focus

Prof. Dr. Xue-jie Yu’s research primarily focuses on emerging infectious diseases, with significant contributions to understanding severe fever with thrombocytopenia syndrome (SFTSV) and other zoonotic diseases. His work spans the discovery of novel viruses, such as the bunyavirus SFTSV, and their epidemiology, transmission, and interaction with the immune system. He investigates the role of vectors like ticks and bats in disease transmission and explores mechanisms of immune evasion by pathogens. His multidisciplinary approach includes molecular biology, microbiology, and epidemiology, contributing valuable insights into public health and disease prevention. 🦠🦟🧬

 

Publication Top Notes

  • Fever with thrombocytopenia associated with a novel bunyavirus in China
    • Cited by: 2045
    • Year: 2011 🦠
  • Haemaphysalis longicornis ticks as reservoir and vector of severe fever with thrombocytopenia syndrome virus in China
    • Cited by: 336
    • Year: 2015 🦟
  • Nosocomial transmission of human granulocytic anaplasmosis in China
    • Cited by: 333
    • Year: 2008 πŸ₯
  • Person-to-person transmission of severe fever with thrombocytopenia syndrome virus
    • Cited by: 310
    • Year: 2012 πŸ§‘β€πŸ€β€πŸ§‘
  • Complete Genome Sequence of Rickettsia typhi and Comparison with Sequences of Other Rickettsiae
    • Cited by: 301
    • Year: 2004 🧬
  • 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
    • Cited by: 297
    • Year: 2020 πŸ“š
  • Bats as reservoirs of severe emerging infectious diseases
    • Cited by: 277
    • Year: 2015 πŸ¦‡
  • Severe fever with thrombocytopenia syndrome virus, Shandong Province, China
    • Cited by: 188
    • Year: 2012 🌍
  • Differentiation among spotted fever group rickettsiae species by analysis of restriction fragment length polymorphism of PCR-amplified DNA
    • Cited by: 188
    • Year: 1994 πŸ”¬
  • Resveratrol inhibits Ξ²-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway
    • Cited by: 179
    • Year: 2013 πŸ‡